A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients-Reference-Cited by-同舟云学术

A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients

Published:2020-10 Issue: Volume:39 Page:46-55
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Vázquez-Bourgon Javier,Ibáñez Alario Miguel,Mayoral-van Son Jacqueline,Gómez Revuelta Marcos,Ayesa Arriola Rosa,Juncal Ruiz María,Ortiz-García de la Foz Víctor,Crespo Facorro Benedicto

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference39 articles.

1. Scale for the Assessment of Negative symptoms (SANS);Andreasen,1983

2. Scale for the Assessment of Positive Symptoms (SAPS);Andreasen,1984

3. Evolution of metabolic risk factors over a two-year period in a cohort of first episodes of psychosis;Bioque;Schizophr. Res.,2018

4. Neural Responsivity to Food Cues in Patients With Unmedicated First-Episode Psychosis;Borgan;JAMA Netw Open,2019

5. Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia;Breier;Am. J. Psychiatry,2005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review and Network Meta-Analysis: Efficacy and Safety of Antipsychotics vs Antiepileptics or Lithium for Acute Mania in Children and Adolescents;Journal of the American Academy of Child & Adolescent Psychiatry;2024-08

2. Comparative analysis of third-generation antipsychotics in first-episode schizophrenia: efficacy, safety, and cognitive impacts. A narrative review;International Clinical Psychopharmacology;2024-06-14

3. Risk factors for abnormal glucose metabolism during antipsychotic treatment: A prospective cohort study;Journal of Psychiatric Research;2023-12

4. Multilocus Genetic Profile Reflecting Low Dopaminergic Signaling Is Directly Associated with Obesity and Cardiometabolic Disorders Due to Antipsychotic Treatment;Pharmaceutics;2023-08-14

5. Metabolic Adverse Effects of Psychotropic Drug Therapy: A Systematic Review;European Journal of Investigation in Health, Psychology and Education;2023-08-12